[{"id":"04040390-17a3-43e6-b00e-89f9b8c6d5c3","acronym":"","url":"https://clinicaltrials.gov/study/NCT01150656","created_at":"2021-01-18T04:34:51.439Z","updated_at":"2024-07-02T16:37:32.040Z","phase":"","brief_title":"Obatoclax Mesylate in Samples From Young Patients With Acute Myeloid Leukemia","source_id_and_acronym":"NCT01150656","lead_sponsor":"Children's Oncology Group","biomarkers":" BCL2","pipe":" | ","alterations":" MLL rearrangement","tags":["BCL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MLL rearrangement"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e obatoclax (GX 15-070)"],"overall_status":"Completed","enrollment":" Enrollment 50","initiation":"Initiation: 06/01/2010","start_date":" 06/01/2010","primary_txt":" Primary completion: 05/01/2016","primary_completion_date":" 05/01/2016","study_txt":"","study_completion_date":"","last_update_posted":"2016-05-18"}]